In STREAM stage 2, this study compared two bedaquiline-containing regimens with the 9-month STREAM stage 1 regimen. Both bedaquiline-containing regimens, a 9-month oral regimen and a 6-month regimen with 8 weeks of second-line injectable, had superior efficacy compared with a 9-month injectable-containing regimen, with fewer cases of hearing loss.
Published: November 8, 2022
Sign up to receive our monthly Research Roundup email, which offers a selection of new public health research from major journals.
Recent Abstracts
Analysing India’s Unique Subnational WHO FCTC Article 5.3 Policies and Their Implementation Across 17…
Strengthening the Tobacco Cessation Ecosystem
Activity Report 2025 – Brazil
More Data Better Health – Brazilian People’s Perceptions of Risk Factors for Cancer
Relatório de Atividades 2025 – Brasil
Mais Dados Mais Saúde – Percepções da população brasileira sobre fatores de risco…
What Primary Care Records Reveal About Cancer Signs and Symptoms
O que os prontuários da atenção primária revelam sobre sinais e sintomas de…
CRVS Performance Measurement and Monitoring Resource Kit
Model Kentucky Ordinance Establishing a County Opioid Abatement Advisory Council